drugset / Trial / NCT00669071
Treatment w/ Tri-Luma® Cream & Intense Pulsed Light (IPL) vs a Mild Inactive Control Cream & Intense Pulsed Light (IPL) in Melasma
RandomizedSingle-groupSingle-blindTreatment
Summary
This study is to evaluate the efficacy and safety of Tri-Luma® Cream (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) when used sequentially with a series of intense pulsed light (IPL) treatments in Subjects diagnosed with moderate to severe melasma during a 10 week treatment period.
Timeline
- Start
- 2008-01
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydroquinone | Small molecule | 4 % | Topical |
| Comparator | Tretinoin | Small molecule | 0.05 % | Topical |
| Comparator | fluocinolone acetonide | Small molecule | 0.01 % | Topical |